Hubert Hondermarck

8.2k total citations
151 papers, 6.0k citations indexed

About

Hubert Hondermarck is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Hubert Hondermarck has authored 151 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 39 papers in Cellular and Molecular Neuroscience and 36 papers in Oncology. Recurrent topics in Hubert Hondermarck's work include Cancer, Stress, Anesthesia, and Immune Response (30 papers), Nerve injury and regeneration (27 papers) and Fibroblast Growth Factor Research (20 papers). Hubert Hondermarck is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (30 papers), Nerve injury and regeneration (27 papers) and Fibroblast Growth Factor Research (20 papers). Hubert Hondermarck collaborates with scholars based in Australia, France and United States. Hubert Hondermarck's co-authors include Xuefen Le Bourhis, B. Boilly, Éric Adriaenssens, Phillip Jobling, Sam Faulkner, Victor Nurcombe, Anne‐Sophie Vercoutter‐Edouart, Ikram El Yazidi‐Belkoura, Jay Pundavela and Marjorie M. Walker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature reviews. Cancer.

In The Last Decade

Hubert Hondermarck

150 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hubert Hondermarck Australia	44	3.2k	1.3k	1.3k	1.2k	1.0k	151	6.0k
L’Houcine Ouafik France	43	2.0k 0.6×	744 0.6×	1.4k 1.1×	276 0.2×	818 0.8×	179	5.0k
Frank Entschladen Germany	37	1.6k 0.5×	1.3k 1.0×	1.4k 1.1×	1.8k 1.5×	499 0.5×	78	4.7k
Brian Harding United Kingdom	46	2.8k 0.9×	909 0.7×	1.0k 0.8×	969 0.8×	278 0.3×	162	6.9k
James Sinnett‐Smith United States	44	4.8k 1.5×	1.1k 0.8×	1.4k 1.1×	174 0.1×	681 0.7×	109	6.9k
Daniel Djakiew United States	39	1.5k 0.5×	856 0.6×	750 0.6×	223 0.2×	454 0.4×	74	3.8k
J K Boyles United States	31	2.7k 0.9×	678 0.5×	521 0.4×	196 0.2×	580 0.6×	42	6.6k
Bernd Niggemann Germany	37	1.6k 0.5×	866 0.7×	1.4k 1.1×	1.1k 0.9×	516 0.5×	81	4.3k
Roberto D. Polakiewicz United States	41	6.7k 2.1×	762 0.6×	1.4k 1.1×	84 0.1×	1.3k 1.2×	69	9.1k
Gang Pei China	36	3.9k 1.2×	1.3k 1.0×	523 0.4×	163 0.1×	670 0.6×	92	5.3k
Davide Schiffer Italy	49	3.2k 1.0×	828 0.6×	1.0k 0.8×	145 0.1×	1.0k 1.0×	266	7.5k

Countries citing papers authored by Hubert Hondermarck

Since Specialization

Citations

This map shows the geographic impact of Hubert Hondermarck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Hondermarck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Hondermarck more than expected).

Fields of papers citing papers by Hubert Hondermarck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubert Hondermarck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Hondermarck. The network helps show where Hubert Hondermarck may publish in the future.

Co-authorship network of co-authors of Hubert Hondermarck

This figure shows the co-authorship network connecting the top 25 collaborators of Hubert Hondermarck. A scholar is included among the top collaborators of Hubert Hondermarck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hubert Hondermarck. Hubert Hondermarck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hondermarck, Hubert, Nataliya Finiuk, Chen Chen Jiang, & Rostyslav Stoika. (2024). Standing strong: War‐related challenges in Ukrainian biomedical research and opportunities for support. FASEB BioAdvances. 6(10). 401–405. 2 indexed citations

Faulkner, Sam, et al.. (2023). The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma. Cancers. 15(9). 2514–2514. 5 indexed citations

Faulkner, Sam, et al.. (2023). Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy. FASEB BioAdvances. 5(5). 211–220. 6 indexed citations

Li, Dong, Ting La, Jun Xing, et al.. (2022). High nerve density in breast cancer is associated with poor patient outcome. FASEB BioAdvances. 4(6). 391–401. 20 indexed citations

Paul, Christine, et al.. (2021). Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole. Neuro-Oncology Advances. 4(1). vdab168–vdab168. 10 indexed citations

Delahunt, Brett, Allison Steigler, Callum Atkinson, et al.. (2021). Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial. Pathology. 54(1). 49–54. 8 indexed citations

March, Brayden, Sam Faulkner, Phillip Jobling, et al.. (2020). Tumour innervation and neurosignalling in prostate cancer. Nature Reviews Urology. 17(2). 119–130. 59 indexed citations

Delahunt, Brett, Allison Steigler, Chris Atkinson, et al.. (2020). Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial. Histopathology. 77(2). 284–292. 24 indexed citations

Nurcombe, Victor, Ling Ling, Hubert Hondermarck, Simon M. Cool, & Raymond A. Smith. (2019). Bringing Heparan Sulfate Glycomics Together with Proteomics for the Design of Novel Therapeutics: A Historical Perspective. PROTEOMICS. 19(21-22). e1800466–e1800466. 4 indexed citations

10.

Faulkner, Sam, Phillip Jobling, Brayden March, Chen Chen Jiang, & Hubert Hondermarck. (2019). Tumor Neurobiology and the War of Nerves in Cancer. Cancer Discovery. 9(6). 702–710. 194 indexed citations

11.

Guo, Su, Xiuli Guo, Rui Yang, et al.. (2017). MicroRNA-645 is an oncogenic regulator in colon cancer. Oncogenesis. 6(5). e335–e335. 24 indexed citations

12.

Bradshaw, Ralph, Jay Pundavela, Jordane Biarc, et al.. (2014). NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling. Advances in Biological Regulation. 58. 16–27. 94 indexed citations

13.

Vanhecke, Elsa, Éric Adriaenssens, Stéphanie Verbeke, et al.. (2011). Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival. Clinical Cancer Research. 17(7). 1741–1752. 101 indexed citations

14.

Adriaenssens, Éric, Elsa Vanhecke, Pasquine Saule, et al.. (2008). Nerve Growth Factor Is a Potential Therapeutic Target in Breast Cancer. Cancer Research. 68(2). 346–351. 160 indexed citations

15.

Chopin, Valérie, Christian Slomianny, Hubert Hondermarck, & Xuefen Le Bourhis. (2004). Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21waf1. Experimental Cell Research. 298(2). 560–573. 76 indexed citations

16.

Descamps, Simon, Valérie Pawlowski, Mohamed Hebbar, et al.. (2001). Expression of nerve growth factor receptors and their prognostic value in human breast cancer. HAL (Le Centre pour la Communication Scientifique Directe). 91 indexed citations

17.

Fernig, David G., Hailan Chen, Hassan Rahmoune, et al.. (2000). Differential Regulation of FGF-1 and -2 Mitogenic Activity Is Related to Their Kinetics of Binding to Heparan Sulfate in MDA-MB-231 Human Breast Cancer Cells. Biochemical and Biophysical Research Communications. 267(3). 770–776. 26 indexed citations

18.

Delehedde, Maryse, et al.. (1996). Heparan Sulfate Proteoglycans Play a Dual Role in Regulating Fibroblast Growth Factor-2 Mitogenic Activity in Human Breast Cancer Cells. Experimental Cell Research. 229(2). 398–406. 46 indexed citations

19.

Hondermarck, Hubert, et al.. (1992). Embryonic brain-derived heparan sulfate inhibits cellular membrane binding and biological activity of basic fibroblast growth factor. Developmental Brain Research. 68(2). 247–253. 14 indexed citations

20.

Hondermarck, Hubert & B. Boilly. (1992). Characterization of fibroblast growth factor binding in regenerating limb blastemas of axolotls.. PubMed. 23. 110–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact